TLC-NOSF Dressings as a First-Line Local Treatment of Chronic Wounds: A Systematic Review of Clinical Evidence
Summary: A 2024 systematic review in WoundCentral Education (Journal of Wound Care) by Meloni et al. analyzed 17 studies spanning from 2017 to 2024, including 10,191 patients and 10,203 chronic wounds (diabetic foot ulcers, leg ulcers, pressure injuries, and others). It evaluates the outcomes when TLC-NOSF dressings were used as first-line treatment—comparing healing efficacy, time-to-heal, quality of life, and cost against standard dressings.
Key Highlights:
- Using TLC-NOSF dressings as first-line care led to significantly higher wound healing rates (around 70–80% by weeks 20–24), faster closure (mean ~7 weeks), and cost savings across diverse wound types. :contentReference[oaicite:0]{index=0}
- Evidence came from both controlled comparative studies (TLC-NOSF vs. standard dressings) and real-world observational data, with low risk of bias overall. :contentReference[oaicite:1]{index=1}
- Results aligned with guideline recommendations (e.g., IWGDF, NICE) endorsing TLC-NOSF as part of standard of care. :contentReference[oaicite:2]{index=2}
Read the full review on WoundCentral Education
Keywords:
TLC-NOSF dressings,
chronic wounds,
wound healing,
cost effectiveness,
quality of life,
first-line treatment